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Commerically manufactured stent graft devices for the
treatment of abdominal aortic aneurysm (AAA) were ap-
proved by the US Food and Drug Administration in 1999.
Since that time, these devices have been increasingly used
to treat AAAs in the United States. Because these devices
are packaged within a sterile sheath delivery system, thereby
shielding the graft material from potential contamination at
the time of implantation, it is generally held that these
devices are less susceptible to prosthetic infection than are
conventionally placed aortic grafts. This report describes a
case of prosthetic infection of an aortic stent graft that
became infected because of a urinary tract infection.
CASE REPORT
A 65-year-old man with a history of coronary artery disease
and diabetes underwent treatment of a 5.8-cm AAA with a 26-
mm  18-cm Ancure endograft device (Guidant Corporation,
Menlo Park, Calif). The device was placed with an open approach
to the right common femoral artery. The left common femoral
artery was exposed surgically to facilitate placement of the con-
tralateral 12F sheath. Both femoral exposures were performed
through transverse skin incisions superior to the inguinal skin
crease. Perioperative antibiotic prophylaxis was given (cefazolin).
The graft deployment procedure was complicated by several issues,
including dislodgement of the pull-wire from the proximal hooks,
extraction of a lodged jacket guard from the iliac limb, and need for
stenting of a kinked contralateral limb. All of these issues were
successfully resolved with endovascular techniques.
After surgery, the patient had a non–Q wave myocardial
infarction. Also, a wound infection of the left groin incision devel-
oped. The wound infection was treated with wound opening with
subsequesnt open wound care and levofloxacin. Cultures from the
wound grew Pseudomonas aeruginosa and Staphylococcus aureus.
The wound was granulating well at the time of hospital discharge.
Three months later, the patient was seen in the emergency
department for a new symptom of back pain. A contrast-enhanced
abdominal computed tomographic (CT) scan was obtained. The
patient was sent home with nonsteriodal therapy for presumed mus-
culoskeletal back pain. He returned 3 days later with worsening back
pain. There was tenderness to palpation of the AAA on abdominal
examiniation. Temperature was 37.6° C, and the patient was ill-
appearing and orthostatic and had a leukocytosis of 20.7/L. A
urinalysis showed bacteruria, and subsequent culture results grew
Enterococcus faecalis. Another CT scan was performed, without con-
trast because of the patient’s dehydration. This CT scan showed an
enlarging AAA diameter, 6.2 cm compared with 5.8 cm at the original
repair. An additional finding of inflammatory changes in the retroperi-
toneum to the left side of the AAA also was noted (Fig 1). Review of
the contrast CT scan performed 3 days earlier showed no endoleak.
The diagnosis of infection of the aortic prosthesis was made. After
intravenous fluid hydration and administration of broad-spectrum
antibiotics (vancomycin hydrochloride, piperacillin/tazobactam, and
levofloxacin), the patient was taken to the operating room for graft
excision. Aortic revascularization was performed with the superficial
femoral-popliteal veins (SFPV) because this has been our preferred
approach for the management of infected aortic prosthese.1,2
First, the SFPV was dissected in both thighs. After the abdo-
men was entered, dense inflammatory changes were noted around
the aorta. The aorta was exposed at the diaphragm for proximal
control. The external iliac arteries were exposed for distal control.
The AAA sac then was opened and a copious amount of purulent
fluid flowed out, as if under pressure. No bleeding was seen from
within the aneurysm sac. The graft was well attached by its hooks,
but otherwise there was no tissue incorporation of the graft. The
graft material was covered in a brownish slime.
After clamping of the supraceliac aorta and the distal aspect of
the graft, the graft was gently dislodged from the aorta proximally
with squeezing of the upper stent and gentle pushing of the stent
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hooks proximally. This process enabled an atraumatic removal of the
proximal attachment site. The aorta then was reclamped below the
renal arteries, as there was otherwise a good proximal aortic neck, and
the supraceliac clamp was removed. This procedure took 13 minutes.
The aortic wall appeared to be healthy otherwise, so the aneurysm sac
was not excised. As has been our practice with the surgical manage-
ment of other aortic prosthetic infections, other maneuvers, such as
omental wrapping and retroperitoneal drainage, were not performed.
The iliac artery hooks were more difficult to remove. Removal
of the hooks on the left common iliac artery damaged the artery,
and bypass to the proximal external iliac artery was necessitated.
Some of the hooks could not be dislodged, so they were cut with
wire cutters. The vein grafts were prepared for placement in a
nonreversed conıguration. Valvulotomy was performed with a
Leather-Mills valvulotome. One SFPV graft was sewn end-to-end
to the aortic neck for the proximal anastomosis. The first SFPV
graft was anastomosed end-to-end to the right external iliac artery.
The second SFPV graft was anastomosed end-to-side to the first
SFPV graft, then end-to-end to the left external iliac artery (Fig 2).
Cultures from the purulent fluid collected at surgery grew E
faecalis, the same organism as isolated from the urinary tract infection.
The patient was treated with a 14-day course of vancomycin hydro-
chloride. After this treatment, Clostridium difficle enterocolitis devel-
oped and was treated with oral metronidazole for 10 days. The patient
was discharged to a rehabilitation facility after 27 days. Unfortunately,
he died of unknown cause 3 weeks later while in the rehabilitation
facility. An autopsy was not performed, but a review of the records
suggests that death was caused by respiratory failure.
DISCUSSION
As with the treatment of standard aortic prosthetic infec-
tions, most reports of endovascular aortic stent graft infections
have used the combination of graft excision and extraana-
tomic bypass for definitive treatment. This is the first reported
case with autogenous aortic reconstruction with the SFPV
after removal of an infected endoluminal aortic prosthesis.
This approach enjoys the same advantages for revacularization
as we have observed with standard aortic graft infections,
principally, in situ revascularization with autogenous material
and avoidance of the patency and reinfection issues that can
accompany extraanatomic bypass. Aortic stump blowout also
is avoided. Although recurrent infection of the vein graft is a
theoretic concern, we have observed only one case of delayed
aortic vein graft disruption in more than 100 cases. This case
was in a SFPV reconstruction for a graft-duodenal fistula.
Because no autopsy was performed, we cannot document that
disruption of the vein graft did not occur in the patient who is
described in our case report. However, the respiratory cause of
death does not suggest this.
Another concern raised by this case is the possibility of
endoluminal prosthetic infection as a result of remote in-
fection, in this case, a urinary tract infection. Although we
cannot absolutely rule out some contribution from the groin
wound infection that occurred after the initial operation, the
culture results indicate that the urinary tract was the source of
the graft infection. The possibility of hematogenous graft
seeding with subsequent infection must be kept in mind with
treatment of patients with endoluminal devices.
The dissection of the pararenal aorta and iliac arteries
was made difficult by the inflammation surrounding the
arteries near the graft attachment sites. This reactive process
was similar to, but not as extensive as, that encountered
with an inflammatory aneurysm. The duodenum was not
Fig 1. CT scan indicates inflammation adjacent to aneurysm sac.
Fig 2. Configuration of SFPV bypass graft for aortic revascular-
ization.
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adherent to the aneurysm sac. In a recent report of five
endoluminal graft explants, aortic control was obtained
below the renal arteries. This was not possible in this case
because the proximal aortic hooks were immediately adja-
cent to the orifices of the renal arteries. Proximal control
was initially obtained at the diaphragm.
Endoluminal prosthetic infection is generally assumed
to occur rarely, given that the grafts are sealed within a delivery
system and, therefore, contact with skin contaminants is un-
likely. However, a review of the literature indicates that there
are at least 18 such cases, including this one (Table).3-14 The
infections of the endoluminal devices appear to be evenly
divided between primary infections of the device and duode-
nal fistulas. The 18 known cases that have occurred rela-
tively early in the overall utilization of endoluminal aneu-
rysm repair would suggest that this might become a more
frequent problem than initially had been anticipated.
Although reports of infected endovascular aortic grafts
are rare, this case shows that graft infection can occur and,
more disturbingly, can occur secondary to remote infec-
tion. Whether the result of infection or other means of
device failure, it is likely that new techniques for open
surgical explantation and complex artic revascularization
will need to be developed as more of these prostheses are
placed. Removal of an endovascular prosthesis that is se-
cured by hooks is possible and leaves an aorta that is suitable
for in situ revascularization. In situ autogenous revascular-
ization with the SFPV is one method of aortic reconstruc-
tion that appears well suited to this problem.
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Summary of reported aortic stent graft infections
Series author, year
Prosthetic
infection
Graft-duodenal
fistula Device
Months until
presentation
Kolvenbach, 1997 1 0 Stentor-Vanguard 14*
Norgren, 1998 0 1 Stentor-Vanguard 17
Hausegger, 1999 0 1 Vanguard 19
Heikkinen, 1999 1 0 Vanguard 3
Makar, 2000 0 1 Zenith 4
Mita, 2000 1 0 Dacron/Z-stent (homemade) 2
Chuter, 2000 0 1† Dacron/Z-stent (homemade) 8
D’Othee, 2000 0 1 Stentor-Vanguard 22
Schlensak, 2001 5 0 Stentor-Vanguard 7, 17, 23, 30, 56
Matsumura, 2001 1 0 Excluder 1
Parry, 2001 0 1‡ AneuRx 6
Ohki, 2001 0 2 ? 9, 30
Jackson, 2002 1 0 Ancure 4
Totals 10 8 Mean: 15.1 months
*Percutaneous access. Isolated iliac artery aneurysm treated with single limb. Prosthetic infection occurred 7 months after removal of infected polytetra-
fluoroethylene femoropopliteal bypass graft.
†Used to treat graft-enteric fistula as primary procedure.
‡Used to treat presumed inflammatory aneurysm (possibly mycotic).
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